Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7299)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2014 (publication date) through Jun 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Borchardt RA, Torres HA. Challenges in managing hepatitis C virus infection in cancer patients. World J Gastroenterol 2014; 20(11): 2771-2776 [PMID: 24659870 DOI: 10.3748/wjg.v20.i11.2771] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i11/2771.htm |
| Number | Citing Articles |
| 1 |
Amy Ly, Heather H Cheng, Laura Alwan. Hepatitis C infection and chemotherapy toxicity. Journal of Oncology Pharmacy Practice 2019; 25(2): 474 doi: 10.1177/1078155217734626
|
| 2 |
Matthias Pinter, Michael Trauner, Markus Peck-Radosavljevic, Wolfgang Sieghart. Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open 2016; 1(2): e000042 doi: 10.1136/esmoopen-2016-000042
|
| 3 |
Kenneth V. I. Rolston. Infections in Cancer Patients with Solid Tumors: A Review. Infectious Diseases and Therapy 2017; 6(1): 69 doi: 10.1007/s40121-017-0146-1
|
| 4 |
Andreas Kyvernitakis, Mahnaz Taremi, Boris Blechacz, Jessica Hwang, Ying Jiang, Parag Mahale, Harrys A. Torres. Impact of hepatitis E virus seropositivity on chronic liver disease in cancer patients with hepatitis C virus infection. Hepatology Research 2015; 45(11): 1146 doi: 10.1111/hepr.12460
|
| 5 |
Romeo-Gabriel Mihăilă. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma. World Journal of Gastroenterology 2016; 22(27): 6214-6223 doi: 10.3748/wjg.v22.i27.6214
|
| 6 |
Noha Hayek, Mona El Lawindi, Hanan Ali Sayed, Amal Sedrak, Zeinab M. Abd. El Hafeez, Amr Shafik Saad. A Single-Institute Cross-sectional Study of HCV-Positive Cancer Patients’ Quality of Life in Egypt. Open Access Macedonian Journal of Medical Sciences 2022; 10(B): 1016 doi: 10.3889/oamjms.2022.6404
|
| 7 |
Tatiana Zorina, Alexis Styche. Infection and Cancer: Bi-Directorial Interactions. 2015; : 295 doi: 10.1007/978-3-319-20669-1_14
|
| 8 |
Barbara Vannata, Emanuele Zucca. Hepatitis C virus-associated B-cell non-Hodgkin lymphomas. Hematology 2014; 2014(1): 590 doi: 10.1182/asheducation-2014.1.590
|
| 9 |
Douaa Sayed, Rania Bakry, Nabiel Mikhail, Medhat Faris, Fatma Rageh, Ahmed Samir Abdelhafiz, Dalia Ghareeb. The prevalence of infection and potential risk factors for HBV and HCV among healthcare workers not vaccinated against HBV: A study from a cancer center in Egypt, 2021–2022. Arab Journal of Gastroenterology 2025; 26(2): 201 doi: 10.1016/j.ajg.2025.01.013
|
| 10 |
Mohammad Ali, Shahid Ud Din Wani, Mubashir Hussain Masoodi, Nisar Ahmad Khan, H.G. Shivakumar, Riyaz M. Ali Osmani, Khalid Ahmed Khan. Global Effect of COVID-19 Pandemic on Cancer Patients and its Treatment: A Systematic Review. Clinical Complementary Medicine and Pharmacology 2022; 2(4): 100041 doi: 10.1016/j.ccmp.2022.100041
|
| 11 |
Isabel Echavarria, J. Rafael Carrión Galindo, Jesús Corral, María Pilar Diz Taín, Fernando Henao Carrasco, Vega Iranzo González-Cruz, Xabier Mielgo-Rubio, Teresa Quintanar, Carlos Rivas Corredor, Pedro Pérez Segura. SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients (2021). Clinical and Translational Oncology 2022; 24(4): 724 doi: 10.1007/s12094-022-02800-3
|
| 12 |
Harrys A. Torres, George B. McDonald. How I treat hepatitis C virus infection in patients with hematologic malignancies. Blood 2016; 128(11): 1449 doi: 10.1182/blood-2016-05-718643
|
| 13 |
Mira Atef, Rasha Eletreby, Mohamed Abdallah, Rasha Salama, Wafaa Elakel, Mohamed Hassany, Wael Abdel-Razek, Yehia El Shazly, Wahid Doss, Gamal Esmat. Efficacy and safety of direct-acting antivirals for HCV in patients with extrahepatic malignancies: real-life experience. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00213-z
|
| 14 |
Kerstin Rauwolf, Heidi Herbrüggen, Stefan Zöllner, Heike Thorer, Olga Makarova, Thomas Kaiser, Aleksandra Pettke, Claudia Rossig, Birgit Burkhardt, Andreas H. Groll. Durable control of hepatitis C through interferon‐free antiviral combination therapy immediately prior to allogeneic haematopoietic stem cell transplantation. Journal of Viral Hepatitis 2019; 26(4): 454 doi: 10.1111/jvh.13046
|
| 15 |
Murad Kiyas oglu Mamedov, T. N Mamedova, Yu. A. Akhmedov. PERSPECTIVES OF INVESTIGATION OF ONCOLOGICAL ASPECTS OF INFECTION CAUSED WITH HEPATITIS C VIRUS. Russian Journal of Oncology 2019; 24(1-2): 39 doi: 10.18821/1028-9984-2019-24-1-2-39-44
|
| 16 |
Nidhi Jyotsana, Michael R. King. The Impact of COVID-19 on Cancer Risk and Treatment. Cellular and Molecular Bioengineering 2020; 13(4): 285 doi: 10.1007/s12195-020-00630-3
|
| 17 |
Vivek R. Bora, Bhoomika M. Patel. The Deadly Duo of COVID-19 and Cancer!. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.643004
|
| 18 |
|
| 19 |
Sima Chaudhari, Satyajit Dey Pereira, Meshach Asare-Warehene, Ritam Naha, Shama Prasada Kabekkodu, Benjamin K. Tsang, Kapaettu Satyamoorthy. Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection. Journal of Ovarian Research 2021; 14(1) doi: 10.1186/s13048-021-00787-z
|
| 20 |
Manjinder Singh Phull, Surender Singh Jadav, Rambabu Gundla, Prathama S. Mainkar. A perspective on medicinal chemistry approaches towards adenomatous polyposis coli and Wnt signal based colorectal cancer inhibitors. European Journal of Medicinal Chemistry 2021; 212: 113149 doi: 10.1016/j.ejmech.2020.113149
|
| 21 |
Andreas Kyvernitakis, Madeleine Duvic, Parag Mahale, Harrys A. Torres. Interferon-Based Treatment for Patients with Mycosis Fungoides and Hepatitis C Virus Infection: A Case Series. American Journal of Clinical Dermatology 2014; 15(5): 451 doi: 10.1007/s40257-014-0084-6
|
| 22 |
Barbara Vannata, Luca Arcaini, Emanuele Zucca. Hepatitis C virus-associated B-cell non-Hodgkin’s lymphomas: what do we know?. Therapeutic Advances in Hematology 2016; 7(2): 94 doi: 10.1177/2040620715623924
|
| 23 |
Eric Chow, Zainab Shahid, Elton T. Smith, Michal Kamionek, Saad Z. Usmani. Successful Treatment of Hepatitis C Infection While Receiving Concurrent Chemotherapy for AL Amyloidosis. Clinical Lymphoma Myeloma and Leukemia 2016; 16(4): 237 doi: 10.1016/j.clml.2016.01.003
|
| 24 |
Saptaparni Ghosh, Minghua L. Chen, Janice Weinberg, Tsion Fikre, Naomi Y. Ko. Hepatitis C Virus Infection and Chemotherapy in Breast Cancer: A Retrospective Chart Analysis. The Oncologist 2020; 25(10): 845 doi: 10.1634/theoncologist.2020-0172
|
| 25 |
Ana Claudia Marques Barbosa Diaz, Steven Sol Witkin, Cesar de Almeida Neto, Alfredo Mendrone Junior, Vanderson Rocha, Silvia Figueiredo Costa, Jessica Fernandes Ramos, Maria Cassia Mendes-Correa. Prevalence and clinical consequences of Hepatitis C virus infection in patients undergoing hematopoietic stem cell transplantation. Revista do Instituto de Medicina Tropical de São Paulo 2024; 66 doi: 10.1590/s1678-9946202466011
|
| 26 |
Juan Pablo Alderuccio, Alexandra Stefanovic, Daniel Dammrich, Jennifer R. Chapman, Francisco Vega, Gennaro Selvaggi, Andreas Tzakis, Izidore S. Lossos. Decreased survival in hepatitis C patients with monomorphic post-transplant lymphoproliferative disorder after liver transplantation treated with frontline immunochemotherapy. Leukemia & Lymphoma 2018; 59(9): 2096 doi: 10.1080/10428194.2017.1413187
|